QIAGEN offers a broad portfolio of stand-alone automated sample and assay technologies. The company holds a leading position in automated nucleic acid purification using membrane-based as well as magnetic particle-based technologies, with platforms such as the award-winning QIAcube® and the EZ1® Advanced, both addressing low-throughput customer needs, or the BioRobot product line for high-throughput DNA and RNA purification.
Combined with any of the state-of-the-art detection technologies, including real-time PCR, capillary electrophoresis, multiplex detection, and Pyrosequencing®, sample processing is highly standardized. Thus, significant advantages are created for laboratories and life science researchers in terms of convenience, cost-efficiency, and quality of results.
With the QIAsymphony® RGQ, the latest addition to the novel laboratory automation systems, this concept was taken a step further and the instrument provides an integrated workflow solution, from preparation of a biological sample to delivery of the final results. The system is extremely flexible, with features including random access and continuous loading, and it can be used with a diverse range of sample types and processing routines as well as with assay kits.
As a proven innovation leader, QIAGEN is committed to continue enabling scientists to explore the building blocks of life, thereby fulfilling its mission of making improvements in life possible.